_nonclinical-safety-assessment-for-small-molecules-and-biologic-drug-development-6of14-redi-2018-preview-1.jpg "Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018 from dbnpa fda Video Screenshot Preview 1")
Gallery_nonclinical-safety-assessment-for-small-molecules-and-biologic-drug-development-6of14-redi-2018-preview-3.jpg "Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018 from dbnpa fda Video Screenshot Preview 3")
Gallery_nonclinical-safety-assessment-for-small-molecules-and-biologic-drug-development-6of14-redi-2018-preview-hqdefault.jpg "Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018 from dbnpa fda Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 44 minutes 31 seconds
👁 View: 5.7K times
Play Audio:👁 View: 5.7K times
Description:
U.S. Food and Drug Administration
U.S. Food and Drug Administration
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_stephen-lynch-asks-califf-what-fda-is-doing-to-guard-against-dangers-of-widespread-ai-adoption.webp "During a House Oversight Committee hearing on Thursday, Rep. Stephen Lynch (D-MA) questioned FDA Commissioner Robert Califf about electrical stimulation devices and the dangers of AI.<br/><br/>Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more:<br/><br/>https://account.forbes.com/membership/?utm_source=youtube&utm_medium=display&utm_campaign=growth_non-sub_paid_subscribe_ytdescript<br/><br/><br/>Stay Connected<br/>Forbes on Facebook: http://fb.com/forbes<br/>Forbes Video on Twitter: http://www.twitter.com/forbes<br/>Forbes Video on Instagram: http://instagram.com/forbes<br/>More From Forbes:http://forbes.com")
⏲ 6:48 👁 5K
_fda-d-i-s-c-o-burst-edition-fda-approval-of-polivy-polatuzumab-vedotin-piiq-for-previously-un.webp "U.S. Food and Drug Administration")
FDA D.I.S.C.O. Burst Edition: FDA approval of Polivy (polatuzumab vedotin-piiq) for previously un...
⏲ 3 minutes 31 seconds 👁 3
_jamie-raskin-flames-paul-gosar-over-remarks-to-the-fda-commissioner-during-a-house-oversight-hearing.webp "At a House Oversight Committee hearing on Thursday, Rep. Jamie Raskin (D-MD) ripped into Rep. Paul Gosar (R-AZ) over his remarks to FDA Commissioner Robert Califf. <br/><br/>Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more:<br/><br/>https://account.forbes.com/membership/?utm_source=youtube&utm_medium=display&utm_campaign=growth_non-sub_paid_subscribe_ytdescript<br/><br/><br/>Stay Connected<br/>Forbes on Facebook: http://fb.com/forbes<br/>Forbes Video on Twitter: http://www.twitter.com/forbes<br/>Forbes Video on Instagram: http://instagram.com/forbes<br/>More From Forbes:http://forbes.com")
Jamie Raskin Flames Paul Gosar Over Remarks To The FDA Commissioner During A House Oversight Hearing
⏲ 5:3 ✓ 16-Apr-2024
_fda-d-i-s-c-o-burst-edition-fda-approval-of-lenvima-lenvatinib-in-combination-with-keytruda.webp "U.S. Food and Drug Administration")
FDA D.I.S.C.O. Burst Edition: FDA approval of Lenvima (lenvatinib) in combination with Keytruda (...
⏲ 3 minutes 30 seconds
_fda-perspectives-on-biosimilar-bla-manufacturing-28of33-quality-oct-16-17-2019.webp "U.S. Food and Drug Administration")
⏲ 24 minutes 48 seconds 👁 955
_stephen-lynch-asks-califf-what-fda-is-doing-to-guard-against-dangers-of-widespread-ai-adoption.jpg)
_fda-d-i-s-c-o-burst-edition-fda-approval-of-polivy-polatuzumab-vedotin-piiq-for-previously-un.jpg)
_jamie-raskin-flames-paul-gosar-over-remarks-to-the-fda-commissioner-during-a-house-oversight-hearing.jpg)
_fda-d-i-s-c-o-burst-edition-fda-approval-of-lenvima-lenvatinib-in-combination-with-keytruda.jpg)
_fda-perspectives-on-biosimilar-bla-manufacturing-28of33-quality-oct-16-17-2019.jpg)
![[+]](/images/menu.gif){kind=small}